Progesterone Antagonist Therapy in a Pelizaeus-Merzbacher Mouse Model

Pelizaeus-Merzbacher disease (PMD) is a severe hypomyelinating disease, characterized by ataxia, intellectual disability, epilepsy, and premature death. In the majority of cases, PMD is caused by duplication of PLP1 that is expressed in myelinating oligodendrocytes. Despite detailed knowledge of PLP...

詳細記述

保存先:
書誌詳細
主要な著者: Prukop, Thomas, Epplen, Dirk B., Nientiedt, Tobias, Wichert, Sven P., Fledrich, Robert, Stassart, Ruth M., Rossner, Moritz J., Edgar, Julia M., Werner, Hauke B., Nave, Klaus-Armin, Sereda, Michael W.
フォーマット: Artigo
言語:Inglês
出版事項: Elsevier 2014
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3980417/
https://ncbi.nlm.nih.gov/pubmed/24680886
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajhg.2014.03.001
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料